Navigation Links
Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event

PARSIPPANY, N.J., Jan. 12, 2011 /PRNewswire/ -- In 2011, what will be the major trends in the pharmaceutical industry?  What will drive innovation?  How will government regulations affect what's next and what's new?  What will the game changers be?  Who will survive in the competitive corporate landscape?  When it comes to market research, what's the smartest and most effective way to get the job done right? The answers to these questions and much more will be revealed at a pivotal, groundbreaking event - the Pharma Market Research Conference on February 1-2, in Parsippany, New Jersey.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research.  This is the most important and impactful event in pharmaceutical market research.  Nowhere else will you find the industry's best and brightest all under one roof!  

Located in the heart of New Jersey's Pharmaceutical Corridor, this event is an essential destination that shines a spotlight on the pharma industry for the world's most noteworthy market research executives.

The Pharma Market Research Conference's impressive advisory board includes senior-level thought leaders from Bayer, Eisai, Johnson & Johnson, Lundbeck, Merck, Pfizer, Purdue, Shire, and Takeda.  With their executive leadership, the Pharma Market Research Conference offers an intensive agenda for anyone wanting to network with and learn from the industry's best.

Talented speakers come from world class companies, including Abbott, Acorda Therapeutics, Alkermes, Allergan, AstraZeneca, Covidien, Daiichi Sankyo, Eisai, Johnson & Johnson, Lundbeck, Merck, Novartis, Pfizer, Roche, Shire, Takeda, ViroPharma & more!  For more about the speakers, go to:

See what exciting innovations and solutions are being offered by 2011's premier sponsors/exhibitors, which include Ipsos Health, Segmedica, Affinnova, A+A Research, BioMedTracker, CBR Pharma Insights, ClarityQMR, Docnography, Dolcera, Drug Development Insights, Epocrates, Financial Times, Healogix, HRA Research, Life Science Analytics, ListenLogic, M3 Global Research, Medefield, MedPredict, Murray Hill Center, National Analysts Worldwide, Northern Light, Optimal Strategix, Reckner, The Research Partnership, Survey Sampling, Toluna, Truth On Call, Verilogue, and WorldOne.

The Pharma Market Research Conference only happens once a year.  More than 200 people came last time; 2011 is expected to be even bigger and better.  For more information or to register, call + or go to:

SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):